Physician profile
Fred K Uthoff
NPI 1639164965
$3,550.70
in general payments reported to CMS, 2019-2025
37 companies · $664 in 2025
The $664 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $858 · 2020: $467 · 2021: $179 · 2022: $487 · 2023: $454 · 2024: $441 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,559.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $500.61 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sunovion Pharmaceuticals INC. | $428.96 | 2019-2022 | |
| Amgen INC. | $401.36 | 2019-2025 | Repatha, Otezla, Repatha |
| Lilly USA, LLC | $317.29 | 2019-2024 | Mounjaro, Jardiance, Emgality |
| Mylan Specialty L.P. | $217.63 | 2019-2024 | Yupelri |
| Astellas Pharma US INC | $159.98 | 2019-2020 | |
| Abbvie INC. | $159.94 | 2022-2025 | Vraylar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $136.72 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $125.25 | 2019-2025 | |
| Medtronic, INC. | $120.48 | 2025 | Inceptiv |
| Dexcom, INC. | $116.11 | 2021-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $113.09 | 2019-2024 | Trelegy Ellipta, Bexsero, Shingrix |
| Pfizer INC. | $107.56 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $63.75 | 2024-2025 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $60.32 | 2023-2024 | Nuedexta, Rexulti |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Uthoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.